Published in Nat Rev Endocrinol on May 27, 2014
Pregravid liver enzyme levels and risk of gestational diabetes mellitus during a subsequent pregnancy. Diabetes Care (2014) 1.47
Two lamprey Hedgehog genes share non-coding regulatory sequences and expression patterns with gnathostome Hedgehogs. PLoS One (2010) 0.96
Windows of the brain: towards a developmental biology of circumventricular and other neurohemal organs. Semin Cell Dev Biol (2007) 0.90
Obesity. Looking at the epigenetic link between obesity and its consequences--the promise of EWAS. Nat Rev Endocrinol (2014) 0.81
Osteoarthritis: Galectin-1 damages cartilage via inflammation. Nat Rev Rheumatol (2016) 0.81
Diabetes: A closer look at the mechanisms of action of colesevelam in humans. Nat Rev Endocrinol (2012) 0.79
Functional genomics: A novel CRISPR-Cas system for easier genome editing? Nat Rev Genet (2015) 0.79
BMD and fracture risk in T2DM-clarifying a paradox. Nat Rev Endocrinol (2011) 0.78
Molecular imaging: magnetic resonance angiography in pulmonary embolism diagnosis. Nat Rev Cardiol (2010) 0.78
Thyroid function: Autoimmunity in pregnancy and ADHD. Nat Rev Endocrinol (2012) 0.77
Therapy: Statin potency is associated with risk of new-onset diabetes in patients with CVD. Nat Rev Endocrinol (2014) 0.77
Bone. Osteocyte-specific activation of the canonical Wnt-β catenin pathway stimulates bone formation. Nat Rev Endocrinol (2015) 0.77
Biomarkers: Is CRP level useful to guide statin therapy? Lack of evidence from HPS fuels the debate. Nat Rev Cardiol (2011) 0.77
Metabolism: an Akt-independent pathway for regulation of gluconeogenesis. Nat Rev Endocrinol (2012) 0.77
Diabetes: Severe hypoglycemia associated with risk of vascular events and death. Nat Rev Cardiol (2010) 0.77
Diabetes. IL-6 mediates the protective effects of exercise on β cells. Nat Rev Endocrinol (2015) 0.77
Diabetes: breast cancer increases diabetes risk. Nat Rev Endocrinol (2013) 0.77
Metabolism: Type 2 immunity at the origin of beige adipocytes. Nat Rev Endocrinol (2014) 0.76
Gene regulation: Landscape and mechanisms of transcription factor cooperativity. Nat Rev Genet (2015) 0.76
Diabetes: aspirin and diabetes mellitus--no increase in bleeding risk? Nat Rev Endocrinol (2012) 0.76
Adrenal gland: New dual-release hydrocortisone tablet for adrenal insufficiency. Nat Rev Endocrinol (2011) 0.76
Vascular disease: cholesterol-efflux capacity might be the key to the protective effects of HDL. Nat Rev Cardiol (2011) 0.76
Reproductive endocrinology: less estrogen, more neuroinflammation? Nat Rev Endocrinol (2012) 0.76
Growth and development: growth hormone therapy improves cognition in children with Prader-Willi syndrome. Nat Rev Endocrinol (2012) 0.76
MHC class II pathway mediates adipose inflammation. Nat Rev Endocrinol (2013) 0.76
Paediatrics: High prevalence of HPA axis suppression in children taking corticosteroids. Nat Rev Endocrinol (2012) 0.75
Reproductive endocrinology: oral contraceptives and VTE risk in PCOS. Nat Rev Endocrinol (2013) 0.75
Diabetes: prevention of heart failure in T1DM-is glycemic control the key? Nat Rev Endocrinol (2011) 0.75
Thyroid function: Thyroid screening in pregnancy--no effect on child cognition? Nat Rev Endocrinol (2012) 0.75
Endocrine disorders in pregnancy: excessive maternal weight increases risk of infant overgrowth. Nat Rev Endocrinol (2012) 0.75
Metabolism. Cilia length--role in energy balance. Nat Rev Endocrinol (2014) 0.75
Diabetes: Hepatic lipogenesis independent of insulin in type 2 diabetes mellitus--a paradox clarified. Nat Rev Endocrinol (2015) 0.75
Diabetes: On trial--bariatric surgery for treatment of type 2 diabetes mellitus. Nat Rev Endocrinol (2012) 0.75
Paediatrics: early growth and vascular change. Nat Rev Endocrinol (2013) 0.75
Adrenal function: Cortisol metabolism during acute stress--an (IC)U turn. Nat Rev Endocrinol (2013) 0.75
Genetics: Fracture risk in acromegaly. Nat Rev Endocrinol (2014) 0.75
New CMR approach to measure diffuse myocardial fibrosis. Nat Rev Cardiol (2010) 0.75
cBAT and rBAT crosstalk to regulate temperature and energy balance. Nat Rev Endocrinol (2013) 0.75
Metabolism: Bacterial-host interplay in circadian regulation of metabolism. Nat Rev Endocrinol (2014) 0.75
Metabolism: Adenosine activates human and murine brown adipose tissue. Nat Rev Endocrinol (2014) 0.75
Obesity: physical activity reduces genetic contribution to obesity risk. Nat Rev Endocrinol (2011) 0.75
Neuroendocrinology: peroxisome proliferation in POMC cells is associated with leptin resistance. Nat Rev Endocrinol (2011) 0.75
Diabetes: Absence of hormone-sensitive lipase associated with risk of T2DM. Nat Rev Endocrinol (2014) 0.75
Atrial fibrillation: Obesity increases risk of AF in women. Nat Rev Cardiol (2010) 0.75
Obesity: promoting a healthy lifestyle in prison inmates-a window of opportunity. Nat Rev Endocrinol (2012) 0.75
Diabetes: Functional β cells detected in long-standing T1DM--a new hope for intervention? Nat Rev Endocrinol (2012) 0.75
Nutrition. Low leptin levels linked with mortality in severely malnourished children. Nat Rev Endocrinol (2014) 0.75
Lead aVR in STEMI diagnosis. Nat Rev Cardiol (2010) 0.75
Therapy: Turner syndrome--estrogen therapy in childhood normalizes pubertal onset. Nat Rev Endocrinol (2014) 0.75
Basic research: From stress to social behaviour-glucocorticoids and dopaminergic circuits pave the way. Nat Rev Endocrinol (2013) 0.75
Pharmacogenetics: Clinical response to antiplatelet therapy--how much does genotype count? Nat Rev Cardiol (2010) 0.75
Thyroid function: new mutation in human TRα proteins. Nat Rev Endocrinol (2014) 0.75
Prevention: Potential benefits of ECG screening in young athletes. Nat Rev Cardiol (2010) 0.75
Add-on treprostinil therapy and PAH. Nat Rev Cardiol (2010) 0.75
Obesity: High teenage BMI increases ESRD risk. Nat Rev Endocrinol (2012) 0.75
Growth and development: enduring effect of GH therapy in PWS. Nat Rev Endocrinol (2013) 0.75
Acute coronary syndromes: should AMI care be regionalized? Nat Rev Cardiol (2010) 0.75
Diabetes: A role for CFTR in β-cell function. Nat Rev Endocrinol (2014) 0.75
Reproductive endocrinology: vitamin D and AMH levels are correlated in human adults. Nat Rev Endocrinol (2012) 0.75
Off-target effects of torcetrapib. Nat Rev Cardiol (2010) 0.75
Evolution: Regulatory evolution of human craniofacial morphology. Nat Rev Genet (2015) 0.75
Antiplatelet therapy: Long-term dual antiplatelet therapy and bleeding in stable patients--insights from CHARISMA. Nat Rev Cardiol (2010) 0.75
Diabetes: which DES is the safest? Nat Rev Cardiol (2011) 0.75
Bone: fracture risk prediction--beyond BMD assessment. Nat Rev Endocrinol (2011) 0.75
Metabolism: no role for osteocalcin in glucose metabolism--challenging a paradigm? Nat Rev Endocrinol (2012) 0.75
Therapy: PMHT and acute pancreatitis risk. Nat Rev Endocrinol (2014) 0.75
Diabetes: Protective role of autophagy in pancreatic β cells. Nat Rev Endocrinol (2014) 0.75
Acute coronary syndromes: Implantable cardiac monitor enables long-term recording of arrhythmias following acute myocardial infarction. Nat Rev Cardiol (2010) 0.75
Prevention: A new model to estimate lifetime risk of CVD. Nat Rev Cardiol (2011) 0.75
Bone: Height loss--a marker of hip fracture risk. Nat Rev Endocrinol (2011) 0.75
Obesity: micronutrient deficiencies after RYGB surgery. Nat Rev Endocrinol (2011) 0.75
Osteoporosis: Not all BMD is created equal. Nat Rev Rheumatol (2016) 0.75
Cardiovascular endocrinology: Obesity-associated risk is reversible. Nat Rev Endocrinol (2011) 0.75
Diabetes: sustained effects of intensive glucose control in established T2DM. Nat Rev Endocrinol (2014) 0.75
Acute coronary syndromes: A single dose of erythropoietin might improve outcomes after STEMI. Nat Rev Cardiol (2010) 0.75
Obesity. BMI-associated genetic variants in FTO mastermind IRX3 expression. Nat Rev Endocrinol (2014) 0.75
Obesity: Is prevalence leveling off? Nat Rev Endocrinol (2012) 0.75
Thyroid gland: Human thyroid gland development and function--angiogenesis in the spotlight. Nat Rev Endocrinol (2014) 0.75
Obesity: Gut-specific FXR agonism. Nat Rev Endocrinol (2015) 0.75
New d-dimer cut-off value helps rule out pulmonary embolism in the elderly. Nat Rev Cardiol (2010) 0.75
Hypertension: white-coat hypertension in the primary-care setting reduced with automated BP measures. Nat Rev Cardiol (2011) 0.75
Diabetes: a Kit for increasing β-cell function. Nat Rev Endocrinol (2012) 0.75
Bringing about lifestyle change. Nat Rev Cardiol (2010) 0.75
Bone: vitamin D metabolites and fracture healing. Nat Rev Endocrinol (2013) 0.75
Bone: Risedronate increases BMD in anorexia nervosa. Nat Rev Endocrinol (2011) 0.75
Parathyroid gland: Which surgery for MEN1 patients? Nat Rev Endocrinol (2012) 0.75
Paediatrics: Cognitive benefits of tight glucose control in critically ill children. Nat Rev Endocrinol (2012) 0.75
Pituitary gland: ESRP1--a regulator of epithelial-mesenchymal transition in somatotroph adenomas? Nat Rev Endocrinol (2012) 0.75
Thyroid gland: TSH mediates increased risk of PTC in Hashimoto thyroiditis. Nat Rev Endocrinol (2011) 0.75
Surgery: Endovascular repair of abdominal aortic aneurysm--the importance of long-term follow-up data. Nat Rev Cardiol (2010) 0.75
Continuous-flow LVAD improves quality of life. Nat Rev Cardiol (2010) 0.75
Valve interventions-a word of caution. Nat Rev Cardiol (2010) 0.75
Pharmacotherapy: Vascular Ehlers-Danlos syndrome. Nat Rev Cardiol (2010) 0.75
Genetics: Meta-analysis identifies variants in 22 loci associated with QRS duration. Nat Rev Cardiol (2011) 0.75
Bone: dental radiography and fracture risk. Nat Rev Endocrinol (2011) 0.75
Antiplatelet therapy. The GRAVITAS of clopidogrel dose. Nat Rev Cardiol (2011) 0.75
Epidemiology: lipid level trends improving in USA. Nat Rev Endocrinol (2012) 0.75
Reproductive endocrinology: A microRNA prevents cervical embryonic implantation. Nat Rev Endocrinol (2014) 0.75
SSRIs associated with fracture risk. Nat Rev Endocrinol (2011) 0.75
Diabetes: antihelminthic drug for T2DM therapy? Nat Rev Endocrinol (2014) 0.75
Obesity: The many faces of leptin--a novel role for leptin signalling in obesity-induced hypertension. Nat Rev Endocrinol (2014) 0.75